TCR2 Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. over the previous period. Total operating expenses were $123,082,000.
Profit Margin
| 2016 | 0 | -9.91M | |
|---|---|---|---|
| 2017 | 0 | -13.07M | |
| 2018 | 0 | -24.25M | |
| 2019 | 0 | -47.59M | |
| 2020 | 0 | -67.12M | |
| 2021 | 0 | -99.80M | |
| 2022 | 0 | -151.82M |
TCRR Income Statement (2016 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|
Revenue | |||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Operating exp. | |||||||
Research and development | 98.64M | 77.23M | 51.98M | 37.48M | 19.67M | 9.56M | 7.67M |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total operating expenses | 123.08M | 99.74M | 68.7M | 51.38M | 26.45M | 13.18M | 9.93M |
Operating income | -153.49M | -99.74M | -68.7M | -51.38M | -26.45M | -13.18M | -9.93M |
Other income (expenses), net | 1.93M | 224K | 1.73M | 3.88M | 2.20M | 110K | 15K |
Income before tax | -151.56M | -99.51M | -66.96M | -47.49M | -24.25M | -13.07M | -9.91M |
Income tax expense | 261K | 289K | 161K | 102K | 2.20M | 110K | 15K |
Net income | -151.82M | -99.80M | -67.12M | -47.59M | -24.25M | -13.07M | -9.91M |
Earnings per share | |||||||
Basic EPS | -3.93 | -2.63 | -2.4 | -2.26 | -1.05 | -2.55 | -1.93 |
Diluted EPS | -3.93 | -2.63 | -2.4 | -2.26 | -1.05 | -2.55 | -1.93 |
| Data source | Data source | Data source | Data source | Data source |